We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+21.49%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$226M
AUM Growth
-$8.34M
Cap. Flow
-$8.34M
Cap. Flow %
-3.69%
Top 10 Hldgs %
19.58%
Holding
125
New
Increased
Reduced
Closed
4

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Technology 25.48%
2 Healthcare 22.54%
3 Communication Services 11.65%
4 Consumer Discretionary 10.83%
5 Financials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
76
Puma Biotechnology
PBYI
$398M
$1.56M 0.69%
73,876
EPAM icon
77
EPAM Systems
EPAM
$5.58B
$1.55M 0.69%
13,631
TTEC icon
78
TTEC Holdings
TTEC
$124M
$1.55M 0.68%
56,105
ASMB icon
79
Assembly Biosciences
ASMB
$498M
$1.52M 0.68%
5,740
AKAM icon
80
Akamai
AKAM
$15.6B
$1.52M 0.67%
24,892
CLR
81
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.5M 0.67%
37,834
MPWR icon
82
Monolithic Power Systems
MPWR
$61.4B
$1.49M 0.66%
12,927
PEGA icon
83
Pegasystems
PEGA
$5.09B
$1.49M 0.66%
62,778
PFBC icon
84
Preferred Bank
PFBC
$1.24B
$1.47M 0.65%
33,915
TTSH
85
DELISTED
Tile Shop Holdings
TTSH
$1.47M 0.65%
269,004
EVC icon
86
Entravision Communication
EVC
$1.02B
$1.47M 0.65%
503,357
LMAT icon
87
LeMaitre Vascular
LMAT
$2.37B
$1.46M 0.65%
62,205
EEFT icon
88
Euronet Worldwide
EEFT
$3.19B
$1.46M 0.65%
14,425
SUPN icon
89
Supernus Pharmaceuticals
SUPN
$2.7B
$1.45M 0.64%
44,665
MDGL icon
90
Madrigal Pharmaceuticals
MDGL
$12.6B
$1.43M 0.63%
13,659
GEO icon
91
The GEO Group
GEO
$4B
$1.43M 0.63%
73,774
FIZZ icon
92
National Beverage
FIZZ
$3.06B
$1.42M 0.63%
39,700
KPTI icon
93
Karyopharm Therapeutics
KPTI
$155M
$1.4M 0.62%
10,230
ACRS icon
94
Aclaris Therapeutics
ACRS
$715M
$1.39M 0.61%
189,437
CASA
95
DELISTED
Casa Systems, Inc. Common Stock
CASA
$1.38M 0.61%
106,908
PNFP icon
96
Pinnacle Financial Partners Inc
PNFP
$15.8B
$1.35M 0.6%
29,448
NTRA icon
97
Natera
NTRA
$36.4B
$1.34M 0.59%
102,617
EGRX
98
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.33M 0.59%
33,939
LOB icon
99
Live Oak Bancshares
LOB
$1.98B
$1.32M 0.59%
89,563
EDIT icon
100
Editas Medicine
EDIT
$399M
$1.32M 0.58%
63,637

Similar funds

Capital Impact Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Capital Impact Advisors held 125 positions worth $226M, down 3.6% from $234M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Capital Impact Advisors withdrew a net $8.34M in Q1 2019, closing 4 positions. Its most notable exit was TESARO, Inc., an estimated $3.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors fully exited TESARO, Inc. in Q1 2019, selling an estimated $3.36M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $226M portfolio in Q1 2019.
  • Capital Impact Advisors opened 0 new positions and closed 4 in Q1 2019.
  • Capital Impact Advisors's portfolio value fell 3.6% quarter-over-quarter to $226M.

Based on Capital Impact Advisors's 13F filing for Q1 2019, filed 17 Apr 2019.